elacestrant
Showing 1 - 10 of 10
Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)
Not yet recruiting
- Breast Cancer
- +3 more
- Elacestrant
- Triptorelin
- (no location specified)
Aug 4, 2023
Metastatic Breast Cancer Trial (Elacestrant)
Not yet recruiting
- Metastatic Breast Cancer
- Elacestrant
- (no location specified)
Oct 24, 2022
Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Badalona, Sant Cugat Del Vallès, Barcelona (Elacestrant)
Completed
- Breast Cancer
- Hormone Receptor Positive Breast Carcinoma
- Elacestrant
-
Badalona, Barcelona, Spain
- +3 more
Oct 25, 2022
ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)
Not yet recruiting
- ER-positive Breast Cancer
- +3 more
- Elacestrant
- +4 more
- (no location specified)
Aug 22, 2022
Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Elacestrant
- +4 more
- (no location specified)
Sep 28, 2022
Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)
Recruiting
- Breast Neoplasms
- +7 more
- Elacestrant
- Abemaciclib
-
Canton, OhioGabrail Cancer Center
Jan 24, 2023
Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)
Completed
- Advanced ER+, HER2-Negative Breast Cancer
- Elacestrant
-
Waltham, MassachusettsRadius Pharmaceuticals, Inc.
Aug 16, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022